Skip to main content
TipRanks
Go Ultimate75% OFF

Bionik Laboratories (BNKL) Ratios

9 Followers

Bionik Laboratories Ratios

BNKL's free cash flow for Q4 2023 was $-757.70K. For the 2023 fiscal year, BNKL's free cash flow was decreased by $-752.00 and operating cash flow was $-756.94K. See a summary of the company’s cash flow.

Financial ratios
RatiosMar 23Mar 22Mar 21Jun 20Mar 19
Liquidity Ratios
Current Ratio1.203.070.841.121.15
Quick Ratio0.752.270.670.921.02
Cash Ratio0.191.330.150.440.14
Solvency Ratio-0.98-5.89-2.44-4.72-3.12
Operating Cash Flow Ratio-1.47-2.78-1.13-1.74-2.82
Short-Term Operating Cash Flow Coverage0.000.00-1.77-4.360.00
Net Current Asset Value$ -2.23M$ 2.84M$ -2.07M$ 626.92K$ 479.41K
Leverage Ratios
Debt-to-Assets Ratio0.720.000.420.110.00
Debt-to-Equity Ratio-1.470.001.130.160.00
Debt-to-Capital Ratio3.130.000.530.140.00
Long-Term Debt-to-Capital Ratio4.180.000.250.000.00
Financial Leverage Ratio-2.051.602.681.391.12
Debt Service Coverage Ratio-44.57-11.49-4.32-10.82-2.12
Interest Coverage Ratio-45.03-5.78-15.19-61.82-2.23
Debt to Market Cap0.780.000.290.250.00
Interest Debt Per Share0.360.140.800.511.38
Net Debt to EBITDA-0.420.21-0.240.010.06
Profitability Margins
Gross Profit Margin54.83%74.84%77.41%58.51%49.78%
EBIT Margin-268.05%-752.35%-1107.33%-1153.30%-224.57%
EBITDA Margin-264.55%-744.29%-1091.43%-1135.62%-213.84%
Operating Profit Margin-267.29%-374.70%-515.76%-522.25%-224.59%
Pretax Profit Margin-273.99%-817.14%-1141.29%-1161.75%-325.21%
Net Profit Margin-273.99%-817.14%-1141.29%-1157.95%-325.20%
Continuous Operations Profit Margin-273.99%-817.14%-1141.29%-1161.75%-325.21%
Net Income Per EBT100.00%100.00%100.00%99.67%100.00%
EBT Per EBIT102.51%218.08%221.28%222.45%144.81%
Return on Assets (ROA)-147.11%-222.59%-155.02%-134.66%-34.41%
Return on Equity (ROE)301.48%-355.56%-415.13%-187.24%-38.51%
Return on Capital Employed (ROCE)-458.24%-149.90%-131.22%-84.45%-26.60%
Return on Invested Capital (ROIC)-448.84%-149.90%-84.28%-73.04%-26.60%
Return on Tangible Assets-153.20%-222.59%-386.23%-416.92%-267.80%
Earnings Yield-179.11%-474.93%-106.24%-302.49%-105.11%
Efficiency Ratios
Receivables Turnover3.984.632.642.492.04
Payables Turnover1.461.050.591.041.42
Inventory Turnover0.790.270.390.844.02
Fixed Asset Turnover4.0813.9612.7513.9716.86
Asset Turnover0.540.270.140.120.11
Working Capital Turnover Ratio1.011.05-67.683.89-1.04
Cash Conversion Cycle305.101087.84459.52229.2712.83
Days of Sales Outstanding91.6178.76138.21146.59179.23
Days of Inventory Outstanding463.111356.58936.98432.8690.83
Days of Payables Outstanding249.63347.51615.67350.18257.23
Operating Cycle554.721435.341075.19579.44270.06
Cash Flow Ratios
Operating Cash Flow Per Share-0.49-0.71-0.90-2.03-3.91
Free Cash Flow Per Share-0.49-0.71-0.90-2.07-3.95
Dividend Paid and CapEx Coverage Ratio-389.62-331.78-1155971.50-56.77-90.71
Capital Expenditure Coverage Ratio-389.62-331.78-1155971.50-56.77-90.71
Operating Cash Flow Coverage Ratio-1.400.00-1.24-4.360.00
Operating Cash Flow to Sales Ratio-1.88-3.26-3.87-4.21-2.84
Free Cash Flow Yield-122.66%-189.81%-36.06%-111.89%-92.94%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-0.56-0.21-0.94-0.33-0.95
Price-to-Sales (P/S) Ratio1.531.7210.743.833.09
Price-to-Book (P/B) Ratio-1.680.753.910.620.37
Price-to-Free Cash Flow (P/FCF) Ratio-0.82-0.53-2.77-0.89-1.08
Price-to-Operating Cash Flow Ratio-0.82-0.53-2.77-0.91-1.09
Price-to-Earnings Growth (PEG) Ratio0.010.010.02-0.010.01
Enterprise Value Multiple-0.99-0.02-1.22-0.33-1.38
Enterprise Value4.75M200.13K15.93M8.05M9.60M
EV to EBITDA-0.99-0.02-1.22-0.33-1.38
EV to Sales2.630.1613.353.742.96
EV to Free Cash Flow-1.40-0.05-3.45-0.87-1.03
EV to Operating Cash Flow-1.40-0.05-3.45-0.89-1.04
Tangible Book Value Per Share-0.260.50-0.390.180.28
Shareholders’ Equity Per Share-0.240.500.642.9911.60
Tax and Other Ratios
Effective Tax Rate0.000.000.000.000.00
Revenue Per Share0.260.220.230.481.37
Net Income Per Share-0.72-1.78-2.66-5.60-4.47
Tax Burden1.001.001.001.001.00
Interest Burden1.021.091.031.011.45
Research & Development to Revenue0.500.781.251.810.98
SG&A to Revenue1.622.203.832.781.61
Stock-Based Compensation to Revenue0.210.340.690.830.42
Income Quality0.680.400.340.360.87

Currency in USD